« Back to Record
Delforge, M., Selleslag, D., Beguin, Y., Triffet, A., Mineur, P., Theunissen, K., Graux, C., André, M., Trullemans, F., Boulet, D., Van Eygen, K., Noens, L., Van Steenweghen, S., Lemmens, J., Pierre, P., D'hondt, R., Ferrant, A., Deeren, D., Van de Velde, A., Wynendaele, W., De Bock, R., Efira, A., Breems, D. D., Deweweire, A., Geldhof, K., Pluymers, W., Harrington, A., MacDonald, K., Abraham, I., & Ravoet, C. (2014). Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes. Leukemia research, 38(5), 557-563. doi:10.1016/j.leukres.2014.02.003
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/183259



